These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14597610)

  • 1. Treating patients of myelodysplastic syndrome with antithymocytic globulin--should we be more selective?
    Madkaikar M; Ghosh K
    Blood; 2003 Nov; 102(10):3851-2; author reply 3852. PubMed ID: 14597610
    [No Abstract]   [Full Text] [Related]  

  • 2. A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome.
    Saunthararajah Y; Nakamura R; Wesley R; Wang QJ; Barrett AJ
    Blood; 2003 Oct; 102(8):3025-7. PubMed ID: 12829603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antilymphocyte globulin for myelodysplastic syndrome.
    Tichelli A; Gratwohl A; Wuersch A; Nissen C; Speck B
    Br J Haematol; 1988 Jan; 68(1):139-40. PubMed ID: 3345291
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-thymocyte globulin therapy induced a spurious increase of fibrinogen degradation products in hypoplastic myelodysplastic syndrome.
    Yahata Y; Isobe Y; Sasaki M; Oshimi K; Sugimoto K
    Eur J Haematol; 2009 May; 82(5):404. PubMed ID: 19191866
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of myelodysplastic syndromes.
    Stadler M; Ganser A
    N Engl J Med; 2005 May; 352(20):2134-5; author reply 2134-5. PubMed ID: 15906434
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful immunosuppressive therapy for a child with Myelodysplastic syndrome.
    Orimoto M; Maeda M; Cai LZ; Hayakawa J; Ueda T; Migita M; Asano T
    Med Pediatr Oncol; 2003 May; 40(5):334-5. PubMed ID: 12652627
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosuppressive therapy for patients with myelodysplastic syndrome: a prospective randomized multicenter phase III trial comparing antithymocyte globulin plus cyclosporine with best supportive care--SAKK 33/99.
    Passweg JR; Giagounidis AA; Simcock M; Aul C; Dobbelstein C; Stadler M; Ossenkoppele G; Hofmann WK; Schilling K; Tichelli A; Ganser A
    J Clin Oncol; 2011 Jan; 29(3):303-9. PubMed ID: 21149672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes.
    Molldrem JJ; Leifer E; Bahceci E; Saunthararajah Y; Rivera M; Dunbar C; Liu J; Nakamura R; Young NS; Barrett AJ
    Ann Intern Med; 2002 Aug; 137(3):156-63. PubMed ID: 12160363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Successful immunosuppressive therapy for a patient with hypoplastic myelodysplastic syndrome].
    Takanashi M; Kadono Y; Tabata Y; Hibi S
    Rinsho Ketsueki; 1999 Oct; 40(10):1093-9. PubMed ID: 10565227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining which patients with myelodysplastic syndrome will respond to immunosuppressive treatment.
    Barrett J; Sloand E; Young N
    Haematologica; 2006 May; 91(5):583-4. PubMed ID: 16670061
    [No Abstract]   [Full Text] [Related]  

  • 11. Outcomes and mutational analysis of patients with lower-risk non-del5q myelodysplastic syndrome treated with antithymocyte globulin with or without ciclosporine A.
    Kelaidi C; Braun T; Arana R; Marceau-Renaut A; Lazarian G; Soret J; Cereja S; Letestu R; Eclache V; Lusina D; Baran-Marszak F; Ades L; Preudhomme C; Martin A; Fenaux P; Gardin C
    Leuk Res; 2018 Aug; 71():67-74. PubMed ID: 30025278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelodysplastic syndrome.
    Nakao S; Deeg HJ; Ishikawa T; Marsh J; List A; Tomonaga M
    Int J Hematol; 2005 Dec; 82(5):412-6. PubMed ID: 16533744
    [No Abstract]   [Full Text] [Related]  

  • 13. Summaries for patients. Promising therapy for bone marrow failure from myelodysplastic syndromes.
    Ann Intern Med; 2002 Aug; 137(3):I-27. PubMed ID: 12160383
    [No Abstract]   [Full Text] [Related]  

  • 14. Myelodysplasia: the good, the fair and the ugly.
    Schiffer CA
    Best Pract Res Clin Haematol; 2007 Mar; 20(1):49-55. PubMed ID: 17336254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polyclonal rabbit antithymocyte globulin (thymoglobulin): immunomodulatory effects and new aspects of its clinical application].
    Kulagin AD; Lisukov IA; Miloserdov IA; Afanas'ev BV
    Ter Arkh; 2010; 82(7):65-72. PubMed ID: 20853613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of selective immunosuppressive therapy on myelodysplastic syndromes in targeted populations results in good response rates and avoids treatment-related disease progression.
    Xiao L; Qi Z; Qiusheng C; Li X; Luxi S; Lingyun W
    Am J Hematol; 2012 Jan; 87(1):26-31. PubMed ID: 22038646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithymocyte globulin (ATG)-based therapy in patients with myelodysplastic syndromes.
    Yazji S; Giles FJ; Tsimberidou AM; Estey EH; Kantarjian HM; O'Brien SA; Kurzrock R
    Leukemia; 2003 Nov; 17(11):2101-6. PubMed ID: 12931212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive therapy with anti-thymocyte globulin and cyclosporine A in selected children with hypoplastic refractory cytopenia.
    Yoshimi A; Baumann I; Führer M; Bergsträsser E; Göbel U; Sykora KW; Klingebiel T; Gross-Wieltsch U; van den Heuvel-Eibrink MM; Fischer A; Nöllke P; Niemeyer C
    Haematologica; 2007 Mar; 92(3):397-400. PubMed ID: 17339190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bit of antithymocyte globulin can take you a long way!
    Mohty M
    Bone Marrow Transplant; 2012 May; 47(5):617-8. PubMed ID: 22569034
    [No Abstract]   [Full Text] [Related]  

  • 20. A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes.
    Stadler M; Germing U; Kliche KO; Josten KM; Kuse R; Hofmann WK; Schrezenmeier H; Novotny J; Anders O; Eimermacher H; Verbeek W; Kreipe HH; Heimpel H; Aul C; Ganser A
    Leukemia; 2004 Mar; 18(3):460-5. PubMed ID: 14712285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.